Oncology

Myelofibrosis

Expert Perspectives in Myelofibrosis to Cover Key Topics in Myelofibrosis Treatment

expert perspectives by John Mascarenhas, MD; Raajit K. Rampal, MD, PhD; Michael Savona, MD

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. Expert Perspectives in Myelofibrosis will feature community-selected experts and topics that we hope you will find of value in your clinical practice.

VIEW THE TOPICS

Expert Roundtables

Disease Progression and Patient Outcomes in Myelofibrosis
Myelofibrosis: Current and Future Goals for Treatment
Overall Approach to Evaluation and Management of Myelofibrosis
Review of the Current Treatment Landscape in Myelofibrosis

Clinical Topic Updates

Addressing Anemia in Patients With Myelofibrosis
Emerging Therapeutic Options for the Treatment of Myelofibrosis
Individualizing Treatment for Patients With Myelofibrosis
Unmet Needs in the Treatment of Myelofibrosis

Patient Care Perspectives

Evaluating Patient Risk Factors When Diagnosing Myelofibrosis
Clinical Challenges and Quality of Life in Patients With Myelofibrosis
Considering Cytopenias in the Management of Myelofibrosis
Treatment Strategies for Patients With Myelofibrosis and Low Platelets

Profile

John Mascarenhas, MD

Professor of Medicine, Division of Hematology/Oncology
Member, The Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY

Profile

Raajit K. Rampal, MD, PhD

Associate Member
Clinical Director, Leukemia Service
Director, Myeloproliferative Neoplasms Program
Memorial Sloan Kettering Cancer Center
New York, NY

Profile

Michael Savona, MD

Beverly and George Rawlings Director of Hematology Research
Professor of Internal Medicine and Cancer Biology
Division of Hematology & Oncology, Department of Medicine
Vanderbilt-Ingram Cancer Center and Vanderbilt University School of Medicine
Nashville, TN